Generated by AI
Fidelity Disruptive Medicine ETF is an actively managed exchange-traded fund focused on companies involved in disruptive innovation across health care. It targets businesses engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, advanced diagnostics, and consumer wellness. The fund seeks exposure to both domestic and foreign issuers, giving investors access to a broad mix of medical technology, biotechnology, life sciences tools, and digital health themes. Its portfolio is designed to capture current developments in modern medicine, with holdings that may include companies supporting research, treatment, testing, and patient care technologies. Fidelity Disruptive Medicine ETF plays a specialized role in the market as a thematic health care fund that concentrates on innovative subsectors shaping how medical services and therapies are developed and delivered.
Summary of Feb 16's posts. Generated by AI.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
Investors talking about FMED also mention these. Each card shows that asset’s own numbers for the past 24 hours.